Thrombophilia medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 12: | Line 12: | ||
The figure has been adapted from Seligsohn ''et al''. N Engl J Med. 2001 Apr 19;344(16):1222-31.<ref name="pmid11309638">{{cite journal |author=Seligsohn U, Lubetsky A |title=Genetic susceptibility to venous thrombosis |journal=N. Engl. J. Med. |volume=344 |issue=16 |pages=1222–31 |year=2001 |month=April |pmid=11309638 |doi=10.1056/NEJM200104193441607 |url=}}</ref> | The figure has been adapted from Seligsohn ''et al''. N Engl J Med. 2001 Apr 19;344(16):1222-31.<ref name="pmid11309638">{{cite journal |author=Seligsohn U, Lubetsky A |title=Genetic susceptibility to venous thrombosis |journal=N. Engl. J. Med. |volume=344 |issue=16 |pages=1222–31 |year=2001 |month=April |pmid=11309638 |doi=10.1056/NEJM200104193441607 |url=}}</ref> | ||
====Contraindicated medications==== | |||
{{MedCondContrAbs | |||
|MedCond = Thrombophilia|Alosetron}} | |||
==References== | ==References== | ||
Revision as of 19:46, 5 February 2015
|
Thrombophilia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombophilia medical therapy On the Web |
|
American Roentgen Ray Society Images of Thrombophilia medical therapy |
|
Risk calculators and risk factors for Thrombophilia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
The treatment algorithm for various thrombophilias is presented below:
The figure has been adapted from Seligsohn et al. N Engl J Med. 2001 Apr 19;344(16):1222-31.[1]
Contraindicated medications
Thrombophilia is considered an absolute contraindication to the use of the following medications: